NEW YORK, May 4 (GenomeWeb News) - Lion Bioscience revenues took a nosedive, while its losses narrowed during its fourth quarter of fiscal year 2003/2004, which ended March 31. The company reported preliminary results for the quarter today.
Lion's revenues plummeted to €3.1 million ($3.7 million), from €9 million ($10.9 million) during the same quarter a year ago.
The company's net loss totaled €4.9 million, down from €18.5 million during the same period last year.
As of March 31, Lion had €43.1 million in cash and cash equivalents.